TrialNeurology(R) neuroimmunology & neuroinflammation2022

Assessing Neurofilaments as Biomarkers of Neuroprotection in Progressive Multiple Sclerosis: From the MS-STAT Randomized Controlled Trial.

Thomas E Williams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.